Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
FDA Panel Recommends Approval of First Therapy for Peanut Allergy
09/18/2019
An FDA advisory committee has recommended the approval of the first therapy for peanut allergies. Following votes in favor of its safety and efficacy, the committee backed approval of an oral immunotherapy that uses fixed doses of powdered...
An FDA advisory committee has recommended the approval of the first therapy for peanut allergies. Following votes in favor of its safety and efficacy, the committee backed approval of an oral immunotherapy that uses fixed doses of powdered...
An FDA advisory committee has...
09/18/2019
Pharmacy Learning Network
News
Off-Label Prescribing Common in Pediatric Ambulatory Care
09/17/2019
"While some off-label use of medicines in children is clinically appropriate and supported by evidence or many years of clinical experience, that is not true for other off-label use," said Daniel B. Horton, MD, Rutgers University.
"While some off-label use of medicines in children is clinically appropriate and supported by evidence or many years of clinical experience, that is not true for other off-label use," said Daniel B. Horton, MD, Rutgers University.
"While some off-label use of...
09/17/2019
Pharmacy Learning Network

Advertisement

News
Oxycontin Maker Purdue Begins Bankruptcy in Push to Settle Opioid Lawsuits
09/17/2019
Purdue Pharma recently filed for bankruptcy after reaching an outline of a deal with states and local governments that have accused the company of deceptively marketing opioids by overstating benefits and downplaying risks.
Purdue Pharma recently filed for bankruptcy after reaching an outline of a deal with states and local governments that have accused the company of deceptively marketing opioids by overstating benefits and downplaying risks.
Purdue Pharma recently filed for...
09/17/2019
Pharmacy Learning Network
News
U.S. CDC Activates Emergency Operations Center for Vaping-Related Illnesses
09/16/2019
The CDC announced it has activated its emergency operations center to coordinate the investigation into hundreds of cases of severe lung illnesses linked to e-cigarette use.
The CDC announced it has activated its emergency operations center to coordinate the investigation into hundreds of cases of severe lung illnesses linked to e-cigarette use.
The CDC announced it has...
09/16/2019
Pharmacy Learning Network
News
Aspirin Likely Beneficial for Primary CVD Prevention in Some Adults, Researchers Say
09/16/2019
According to recent research, the benefit of aspirin therapy may outweigh the bleeding risk for some adults who do not have heart disease.
According to recent research, the benefit of aspirin therapy may outweigh the bleeding risk for some adults who do not have heart disease.
According to recent research,...
09/16/2019
Pharmacy Learning Network

Advertisement

News
Procalcitonin-Guided Therapy Significantly Reduces Antibiotics Duration
09/16/2019
"[Procalcitonin]-guided [antibiotic therapy] adherence appears safe for patients with [ventilator-associated pneumonia] and is likely to reduce exposure to antibiotics," researchers wrote.
"[Procalcitonin]-guided [antibiotic therapy] adherence appears safe for patients with [ventilator-associated pneumonia] and is likely to reduce exposure to antibiotics," researchers wrote.
"[Procalcitonin]-guided...
09/16/2019
Pharmacy Learning Network
News
Pharmacist-Conducted Discharge Medication Reconciliation Impact on COPD Readmission Rates
09/16/2019
Researchers recently examined how pharmacist-conducted medication reconciliation at patient discharge impacted 30-day readmission rates for people with chronic obstructive pulmonary disease.
Researchers recently examined how pharmacist-conducted medication reconciliation at patient discharge impacted 30-day readmission rates for people with chronic obstructive pulmonary disease.
Researchers recently examined...
09/16/2019
Pharmacy Learning Network
News
Multidisciplinary Approach Needed to Optimize Post-Surgery Opioid Use
09/12/2019
Efforts to optimize opioid prescribing and pain treatment after surgery should consider the interacting perspectives of the patient, the perioperative team, and the pharmacist.
Efforts to optimize opioid prescribing and pain treatment after surgery should consider the interacting perspectives of the patient, the perioperative team, and the pharmacist.
Efforts to optimize opioid...
09/12/2019
Pharmacy Learning Network

Advertisement

News
Remote Antimicrobial Stewardship Advice Cuts Broad-Spectrum Antibiotic Use
09/12/2019
Researchers found that a telehealth-based antimicrobial stewardship program reduced prescribing of broad-spectrum antibiotics by nearly 25%.
Researchers found that a telehealth-based antimicrobial stewardship program reduced prescribing of broad-spectrum antibiotics by nearly 25%.
Researchers found that a...
09/12/2019
Pharmacy Learning Network
News
Use of Warfarin Dosing Algorithms Decreases With Experience
09/12/2019
While most anticoagulation providers use warfarin dosing algorithms, many give up the tool with experience, according to a recent study.
While most anticoagulation providers use warfarin dosing algorithms, many give up the tool with experience, according to a recent study.
While most anticoagulation...
09/12/2019
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use